A39.F Arjo AB (publ)

Healthcare Health Care Providers & Services Frankfurt Exchange
3.54 EUR
Close of Nov 12, 2026
2.11 3.35
Market cap
EUR 900M
P/E
27.5x
P/B
1.25x
ROE
4.8%
Dividend yield
2.62%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is A39.F undervalued?

Graham number
Price3.54
Graham value2.87
Premium23.4%

A39.F trades 23.4% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Arjo AB (publ) fundamental analysis

No fundamental analysis for Arjo AB (publ) yet.

Arjo AB (publ) stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Arjo AB (publ)

Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and the Pacific. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, hygiene, prevention of pressure injuries and blood clots, and leg ulcer treatment and prevention, as well as for obstetric and cardiac diagnostics. The company a…

Full company profile